Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David K Cole

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Molecular Therapy Oncolytics|April 11, 2022
Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10Emily A Bates, James A Davies, Jana Váňová, et al.
European Journal of Immunology|May 16, 2019
TCR-induced alteration of primary MHC peptide anchor residueFlorian Madura, Pierre J Rizkallah, Mateusz Legut, et al.
European Journal of Immunology|February 2, 2022
Structure-guided stabilization of pathogen-derived peptide-HLA-E complexes using non-natural amino acids conserves native TCR recognitionClaire Barber, Victoria Arena De Souza, Rachel L Paterson, et al.
Nature Immunology|January 17, 2012
Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetesAnna M Bulek, David K Cole, Ania Skowera, et al.
The Journal of Biological Chemistry|June 30, 2023
High-affinity CD8 variants enhance the sensitivity of pMHCI antigen recognition via low-affinity TCRsLea Knezevic, Tassilo L A Wachsmann, Ore Francis, et al.
The Journal of Biological Chemistry|September 7, 2012
T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targetingJulia Ekeruche-Makinde, Mathew Clement, David K Cole, et al.
Nature Medicine|November 11, 2008
Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptorAngel Varela-Rohena, Peter E Molloy, Steven M Dunn, et al.
Nature Communications|September 10, 2022
Therapeutic high affinity T cell receptor targeting a KRAS<sup>G12D</sup> cancer neoantigenAndrew Poole, Vijaykumar Karuppiah, Annabelle Hartt, et al.
Cell Reports|May 31, 2024
A targeted single mutation in influenza A virus universal epitope transforms immunogenicity and protective immunity via CD4<sup>+</sup> T cell activationSarah Hulin-Curtis, James K Geary, Bruce J MacLachlan, et al.
Blood|December 21, 2012
Peptide length determines the outcome of TCR/peptide-MHCI engagementJulia Ekeruche-Makinde, John J Miles, Hugo A van den Berg, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Molecular Therapy Oncolytics|April 11, 2022
Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10Emily A Bates, James A Davies, Jana Váňová, et al.
European Journal of Immunology|May 16, 2019
TCR-induced alteration of primary MHC peptide anchor residueFlorian Madura, Pierre J Rizkallah, Mateusz Legut, et al.
European Journal of Immunology|February 2, 2022
Structure-guided stabilization of pathogen-derived peptide-HLA-E complexes using non-natural amino acids conserves native TCR recognitionClaire Barber, Victoria Arena De Souza, Rachel L Paterson, et al.
Nature Immunology|January 17, 2012
Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetesAnna M Bulek, David K Cole, Ania Skowera, et al.
The Journal of Biological Chemistry|June 30, 2023
High-affinity CD8 variants enhance the sensitivity of pMHCI antigen recognition via low-affinity TCRsLea Knezevic, Tassilo L A Wachsmann, Ore Francis, et al.
The Journal of Biological Chemistry|September 7, 2012
T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targetingJulia Ekeruche-Makinde, Mathew Clement, David K Cole, et al.
Nature Medicine|November 11, 2008
Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptorAngel Varela-Rohena, Peter E Molloy, Steven M Dunn, et al.
Nature Communications|September 10, 2022
Therapeutic high affinity T cell receptor targeting a KRAS<sup>G12D</sup> cancer neoantigenAndrew Poole, Vijaykumar Karuppiah, Annabelle Hartt, et al.
Cell Reports|May 31, 2024
A targeted single mutation in influenza A virus universal epitope transforms immunogenicity and protective immunity via CD4<sup>+</sup> T cell activationSarah Hulin-Curtis, James K Geary, Bruce J MacLachlan, et al.
Blood|December 21, 2012
Peptide length determines the outcome of TCR/peptide-MHCI engagementJulia Ekeruche-Makinde, John J Miles, Hugo A van den Berg, et al.
Pageof 11